The State of Anterior Segment

ByJoshua Mali, MD

In this episode, Cathleen M. McCabe, MD, chief medical officer of Eye Health America, shares her insights and perspectives on intraocular lenses, MIGS, dry eye and more.

Intro :14
In this episode :21
About Cathleen M. McCabe, MD :28
What is your favorite intraocular lens implant to use and why? 2:24
What is your favorite minimally invasive glaucoma surgery (MIGS) to use and why? 4:03
What is your favorite dry-eye treatment to use and why? 4:49
What’s your preferred technique for secondary IOLs? 6:29
How has the role of women in ophthalmology changed throughout the years? 8:46
How did you get involved with international work? How has the pandemic affected this? 10:55
Tell us about your mission work. What are you currently involved in? 12:54
What is the most important topic/issue/challenge facing ophthalmology now or in the future? 15:11
Final words from Dr. McCabe 16:46

Cathleen M. McCabe, MD, is chief medical officer of Eye Health America; medical director of The Eye Associates and president of Outpatient Ophthalmic Surgery Society.

We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN.

To learn more about the Global Education & Research Society of Ophthalmology (or GERSO), visit https://www.gerso.org.

Published by:

Sources/Disclosures

Collapse

Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; grant/research support from Alimera Sciences, Allergan/AbbVie, Chengdu Kanghong Biotechnology, Genentech, Notal Vision, Regeneron and Santen; consulting for Alimera Sciences, Allergan/AbbVie, Eyepoint Pharmaceuticals, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis and Sun Pharmaceuticals; and stock/shareholder with AbbVie and Regeneron. McCabe reports consultant relationships with Alcon, Allergan, Bausch and Lomb, Dompe, EyePoint Pharmaceuticals, Ivantis, Novartis, Ocular Therapeutix, Omeros, Sight Sciences and Zeiss. She reports research roles with Alcon, Allergan, Bausch and Lomb, EyePoint Pharmaceuticals, Glaukos, Ivantis, Johnson & Johnson, Ocular Therapeutix and Ora. She also reports an investor relationship with Ocular Innovations.

Read more

The State of Anterior Segment

Eye Care Insider

Related Content